Solventum Corporation

Solventum Corporation

SOLVยทNYSE

$78.36

+2.5%
HealthcareMedical - Care Facilities

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.

At a Glance

Live Snapshot
Market Cap$13.57B
EPS8.9400
P/E Ratio8.77
Earnings Date08/06/2026
3Y+2.0%
5Y+14.0%
10Y+14.0%
3Y+16.0%
5Y+37.0%
10Y+37.0%
3Y-78.0%
5Y-82.0%
10Y-82.0%
Solventum Corporation

Solventum Corporation Profit Bridge

SOLV ยท NYSE
Revenue8.32B
Cost of Goods Sold (3.87B)
Gross Profit4.45B
Operating Expenses (2.27B)
Operating Income2.18B
Interest Expense (347.00M)
Other Income/Expense-468.00M
Pretax Income1.71B
Income Tax (157.00M)
Net Income1.56B
Net Income
1.56B

Profitability Analysis

Gross Margin

53.5%

Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.

Operating Margin

26.2%

Outstanding operational efficiency. The company generates substantial profit from core operations.

Net Profit Margin

18.7%

Strong net margins indicate efficient operations and favorable tax/interest management.

Effective Tax Rate

9.2%

Below-average tax rate suggests effective tax planning, favorable jurisdictions, or tax credits.

Profitability Insight

Exceptional profitability across all levels: Strong pricing power, efficient operations, and healthy bottom line indicate a high-quality business with sustainable competitive advantages.

Solventum Corporation Income Statement

SOLV โ€ข NYSE

Solventum Corporation Income StatementDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
REVENUE
8.3B
8.3B
8.2B
8.1B
8.2B
7.3B
GROSS PROFIT
(3.9B)
(3.7B)
(3.5B)
(3.4B)
(3.2B)
(3B)
4.5B
4.6B
4.7B
4.7B
4.9B
4.3B
OPERATING INCOME
(2.3B)
(3.6B)
(3B)
(3B)
(3B)
(2.9B)
(3.1B)
(2.8B)
(2.2B)
(2.2B)
(2.3B)
(2.2B)
(739M)
(775M)
(758M)
(767M)
(766M)
(719M)
2.2B
1B
1.7B
1.7B
1.9B
1.4B
PRE-TAX INCOME
(347M)
(367M)
(0.0)
(0.0)
(0.0)
(0.0)
-347M
-367M
0.0
0.0
0.0
0.0
-1.5B
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
-468M
-431M
-25M
-1M
3M
10M
1.7B
605M
1.7B
1.7B
1.9B
1.4B
NET INCOME
(157M)
(127M)
(321M)
(349M)
(422M)
(302M)
1.6B
479M
1.3B
1.3B
1.5B
1.1B

SEC Filings

SOLV - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
8-K

8-K 2026

N/A

May 27, 2026
May 21, 2026
2026
8-K

8-K 2026

N/A

May 20, 2026
May 15, 2026
2026
10-Q

10-Q 2026 Q1

Q1

May 05, 2026
March 31, 2026
2026
8-K

8-K 2026

N/A

May 05, 2026
May 05, 2026
2026
DEF 14A

DEF 14A 2025

N/A

March 27, 2026
December 31, 2025
2025
8-K

8-K 2026

N/A

March 24, 2026
March 20, 2026
2026
10-K

10-K 2025 FY

FY

February 27, 2026
December 31, 2025
2025
8-K

8-K 2026

N/A

February 26, 2026
February 26, 2026
2026
8-K

8-K 2025

N/A

December 16, 2025
December 16, 2025
2025
10-Q

10-Q 2025 Q3

Q3

November 06, 2025
September 30, 2025
2025
Showing 1 to 10 of 40 filings